| Date | Form | Description | Docs | XBRL | Pages |
| 03/17/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
52 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 09/09/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/10/09 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/12/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 09/19/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
39 |
Latest News & Events
Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study
Read More...Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology
Read More...Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.